Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor (original) (raw)
Related papers
Pyrazine-based Syk kinase inhibitors
Bioorganic & Medicinal Chemistry Letters, 2012
Recent progress in cancer therapeutics
Translational oncology, 2009
Redesigning Kinase Inhibitors to Enhance Specificity
Journal of Medicinal Chemistry, 2008
Anti-Cancer Drugs: Molecular Mechanisms of Action
Mini-Reviews in Medicinal Chemistry, 2005
Inhibitors that target protein kinases for the treatment of ovarian carcinoma
American Journal of Obstetrics and Gynecology, 2003
Alam et al 2008 Braz J Pharmacog
Dual enkephalinase inhibitor (DENKI) PL265
PAIN, 2018
Cancer Chemotherapy: Combination with Inhibitors (Volume I)
Cancers, 2024
Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases
ACS Medicinal Chemistry Letters, 2010
PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity
Clinical Cancer Research, 2006
Specific delivery of kinase inhibitors in nonmalignant and malignant diseases
Expert Opinion on Drug Delivery, 2011
Compounds for Use in the Treatment of Cancer
3,5-Diarylazoles as novel and selective inhibitors of protein kinase D
Bioorganic & Medicinal Chemistry Letters, 2011
Anticancer alkaloid lamellarins inhibit protein kinases
Marine drugs, 2008
Kinase Inhibitors from Marine Sponges
Marine Drugs, 2011
Bioassays for Anticancer Activities
Methods in Molecular Biology, 2013
Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters, 2013
International Journal of Drug Development and Research
Malaysian Journal of Pharmacy
MEN15658: a new promising anti-tumoral drug active on resistant tumor cells
Anti-Cancer Drugs, 2004
Annals of Oncology, 2017
A Peptide Library Approach Identifies a Specific Inhibitor for the ZAP-70 Protein Tyrosine Kinase
Molecular Cell, 2000
In silico ADME/T and 3D QSAR analysis of KDR inhibitors
Journal of Applied Pharmaceutical Science, 2017
1-Acetyl- r -2, c -6-di-2-furyl-3,5-dimethylpiperidin-4-one
Acta Crystallographica Section E Structure Reports Online, 2007
Haemophilia, 2010
5-Aminopyrimidin-2-ylnitriles as Cathepsin K inhibitors
Bioorganic & Medicinal Chemistry Letters, 2009
Journal of Pharmaceutical and Biological Research
2014
11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry
Pharmaceuticals, 2016
F1000 - Post-publication peer review of the biomedical literature, 2009
ErbB receptor tyrosine kinase inhibitors as therapeutic agents
Frontiers in Bioscience, 2002
International Journal of Pharmaceutical Sciences Letters
A novel anti-melanoma SRC-family kinase inhibitor
Oncotarget, 2019
8,11-Dihydroxypentacycloundecane-8,11-lactam
Acta Crystallographica Section E Structure Reports Online, 2005
IAP-targeted therapies for cancer
Oncogene, 2008
Understanding how kinase-targeted therapies work
Cell Cycle, 2008